CLBT – cellebrite di ltd. - ordinary shares (US:NASDAQ)
Stock Stats
News
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at JPMorgan Chase & Co. from $22.00 to $24.00. They now have an "overweight" rating on the stock.
D-Fend Solutions Raises $31M to Fortify Cyber Counter-Drone Technology and Market Leadership
Cellebrite Announces Participation in the UBS Global Technology and AI Conference
Cellebrite and Relativity Deliver Solutions to Transform the Mobile Data Collection Landscape
Is Cellebrite (CLBT) Poised to Develop And Sell The Next Generation Of AI Analytics Tools? [Yahoo! Finance]
Form 144 Cellebrite DI Ltd. Filed by: Keinan Elly
Form 144 Cellebrite DI Ltd. Filed by: Baudot-Trajtenberg Nadine
Form 144 Cellebrite DI Ltd. Filed by: Baudot-Trajtenberg Nadine
Form 144 Cellebrite DI Ltd. Filed by: Gruber Dafna
Form 144 Cellebrite DI Ltd. Filed by: Shapira Ayala Berler
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.